Article Name Clinical & Diagnostic
Cepheid Receives CE Marking Under IVDR for Xpert GI Panel
IVDR-compliant PCR test supports the detection of 11 clinically relevant gastrointestinal pathogens from 1 sample
13th May, 2026
Sebia India Collaborates with CAHO to Launch Autoimmunity Masterclass Series to Strengthen Early Diagnosis and Clinical Excellence
India Sebia, in collaboration with CAHO Diagnostic Division, is proud to announce the launch of the Autoimmunity Masterclass Series—a six-part academic webinar initiative aimed at advancing the understanding, early diagnosis, and clinical management of autoimmune diseases.
11th May, 2026
Ventric Health Updates Digital Platform to Support Earlier Heart Failure Detection
The redesigned website expands clinical evidence, workflow guidance and access pathways for the Vivio System, an FDA-cleared non-invasive device used to measure elevated left ventricular end-diastolic pressure in outpatient settings.
08th May, 2026
Chance Pharma’s CXG87 Moves Into China Regulatory Review for Asthma Treatment
The NMPA acceptance of Chance Pharma’s first new drug application advances CXG87, an improved budesonide/formoterol dry powder inhalation therapy, toward potential commercialisation in China.
08th May, 2026
Getting a leg up on diabetic lower extremity amputation with new AI risk prediction model
Jointly developed by SGH, SingHealth and MOHT, LEA-Net uses patient data to identify individuals at higher risk of lower extremity amputation three to five years before foot ulcers and infections develop.
08th May, 2026
FutureLife Becomes First European Fertility Network to Adopt an End-to-End AI Fertility Platform
Network-wide partnership with Alife Health brings a comprehensive AI platform for fertility care, including CE-marked Embryo Predict, to clinics across 16 countries
06th May, 2026
Dentsply Sirona Introduces AI-Powered PARL Detection Solution
The AI-assisted support feature is designed to help clinicians review CBCT scans more efficiently and clearly when evaluating potential periapical radiolucencies (PARLs)
04th May, 2026
NAMSA and Lexitas Partner to Deliver End-to-End Ophthalmic Medical Device Development
Strategic collaboration combines global MedTech development capabilities with specialised ophthalmic expertise to streamline innovation
30th April, 2026
An app that improves decision-making: Duke-NUS study shows myKIDNEY helps patients make better informed choices
Duke-NUS researchers find that pairing a web-based decision-aid with counselling helps elderly patients with end-stage kidney disease and their caregivers make better informed treatment choices – and significantly shifts decisions towards care that prioritises comfort and quality of life.
30th April, 2026
Pulse Biosciences Reports Positive Outcomes for nPulse Cardiac Catheter System at Rhythm 2026
Late-breaking data demonstrate strong durability and procedural efficiency, reinforcing potential of nanosecond pulsed field ablation in atrial fibrillation treatment
27th April, 2026
Boston Scientific Highlights Data-Driven Cardiac Therapies at Rhythm 2026
Focus on real-time data insights and connected monitoring underscores shift toward precision cardiac care and improved clinical decision-making
27th April, 2026
The Neuron Clinic Expands Brain PET Capabilities with Additional NeuroLF Systems to Advance Alzheimer’s Diagnosis
Deployment of compact point-of-care brain PET scanners reflects growing demand for earlier, accessible neurodiagnostics in community settings
24th April, 2026
Team ASSURE clinches top prize at NUS–SYNAPXE–IMDA AI Innovation Challenge 2026 with home monitoring platform for cardiac recovery
AI-powered solutions for cardiac monitoring, elderly care, and clinical workflows take centre stage as student teams showcase real-world healthcare innovations
22nd April, 2026
Vapotherm Secures FDA Clearance for All Patient Circuit to Expand High Velocity Therapy Across Patient Populations
Single disposable circuit enables respiratory support from neonatal to adult patients, simplifying workflows and improving care continuity
22nd April, 2026
Genentech Advances Gazyva® for Lupus with FDA Acceptance of New Application
Regulatory milestone expands potential use of anti-CD20 therapy in lupus, building on prior success in lupus nephritis
21st April, 2026
Bracco Secures Health Canada Approval for Vueway® to Advance Lower-Dose MRI Contrast Imaging
Gadopiclenol-based contrast agent enables high-quality imaging at reduced gadolinium exposure, supporting safer diagnostic workflows
20th April, 2026
CStone Reveal Preclinical Data on Next-Generation ADCs Targeting EGFR/HER3 and Tumor Heterogeneity
CStone presents preclinical data on three differentiated antibody-drug conjugates, including a dual-target EGFR/HER3 candidate
20th April, 2026
Sonire Secures $18Mn Series A to Accelerate HIFU Cancer Treatment Development
Led by Santé, the funding will support completion of the world's first randomised HIFU trial for pancreatic cancer, and accelerate U.S. clinical programs for the company's anaesthesia-free, outpatient sonic therapy
20th April, 2026
Medtech Special
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer